Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Ekso Bionics Holdings (EKSO) Accumulated Depreciation & Amortization (2016 - 2025)

Ekso Bionics Holdings (EKSO) has disclosed Accumulated Depreciation & Amortization for 12 consecutive years, with $3.8 million as the latest value for Q4 2025.

  • On a quarterly basis, Accumulated Depreciation & Amortization rose 12.36% to $3.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $3.8 million, a 12.36% increase, with the full-year FY2025 number at $3.8 million, up 12.36% from a year prior.
  • Accumulated Depreciation & Amortization was $3.8 million for Q4 2025 at Ekso Bionics Holdings, up from $3.3 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $3.8 million in Q4 2025 to a low of $887000.0 in Q4 2022.
  • A 5-year average of $2.4 million and a median of $3.2 million in 2023 define the central range for Accumulated Depreciation & Amortization.
  • Peak YoY movement for Accumulated Depreciation & Amortization: fell 13.29% in 2022, then surged 255.81% in 2023.
  • Ekso Bionics Holdings' Accumulated Depreciation & Amortization stood at $1.0 million in 2021, then dropped by 13.29% to $887000.0 in 2022, then soared by 255.81% to $3.2 million in 2023, then increased by 5.86% to $3.3 million in 2024, then grew by 12.36% to $3.8 million in 2025.
  • Per Business Quant, the three most recent readings for EKSO's Accumulated Depreciation & Amortization are $3.8 million (Q4 2025), $3.3 million (Q4 2024), and $3.2 million (Q4 2023).